Results 181 to 190 of about 155,675 (375)

218 Mechanisms of increased IgE synthesis in acute graft vs. host disease (GVHD)

, 1983
J A Saryan, D LEUNG, Jay Rappaport, Robertson Parkman, Raif S. Geha   +4 more
openalex   +1 more source

A DECREASE IN GRAFT-VS.-HOST DISEASE WITHOUT LOSS OF GRAFT-VS.-LEUKEMIA REACTIVITY AFTER MHC-MATCHED BONE MARROW TRANSPLANTATION BY SELECTIVE DEPLETION OF DONOR NK CELLS IN VIVO

, 1992
Bryon D. Johnson, Robert L. Truitt
openalex   +1 more source

Inflammatory pseudotumor of the lung following invasive aspergillosis in a patient with chronic graft‐vs.‐host disease [PDF]

, 2005
Constanze Priebe‐Richter, Philipp Ivanyi, Jan Buer, Florian Länger, Joachim Lotz, Bernd Hertenstein, Arnold Ganser, Anke Franzke   +7 more
openalex   +1 more source

The Gut‐Brain Axis in Parkinson disease: Emerging Concepts and Therapeutic Implications

Movement Disorders Clinical Practice, EarlyView.
Abstract Background The gut‐brain axis, i.e. the bidirectional communication system between the gut and the brain, has become of central importance in Parkinson disease (PD) research over the past 20 years. Aims We aimed to describe the milestones of the gut‐brain axis research in PD and the development of theories proposing the involvement of the ...
Elisa Menozzi, Anthony H.V. Schapira, Per Borghammer   +2 more
wiley   +1 more source

Prevention of acute graft-vs.-host disease by targeting glycolysis and mTOR pathways in activated T cells. [PDF]

Exp Ther Med, 2022
Zhou RQ, Wang X, Ye YB, Lu B, Wang J, Guo ZW, Mo WJ, Yang Z, Srisuk P, Yan LP, Xu XJ.   +10 more
europepmc   +1 more source

Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen

, 1999
Michele Pelot, Denise A. Pearson, Kirsten Swenson, Guiling Zhao, Jessica Sachs, Yong‐Guang Yang, Megan Sykes   +6 more
openalex   +1 more source

The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery [PDF]

, 2006
Francesca Patriarca, Cristina Skert, Alessandra Sperotto, Francesco Zaja, Edmondo Falleti, Rosalba Mestroni, Francesca Kikic, Elisabetta Calistri, Carla Filì, Antonella Geromin, Michela Cerno, Renato Fanin   +11 more
openalex   +1 more source

Barriers to Hematopoietic Stem Cell Transplant Among Caregivers and Adolescents With Sickle Cell Disease

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Hematopoietic stem cell transplantation (HSCT) is a curative treatment for sickle cell disease (SCD). However, barriers exist that prevent access to this treatment modality. Methods An IRB‐approved mixed‐method survey of barriers to HSCT in SCD was given to parents, caregivers, and adolescents obtaining care at the Children's of ...
Chibuzo Ilonze, Alexandria Broadnax, Hilary Haines, Jeffrey Lebensburger, Frederick Goldman   +4 more
wiley   +1 more source

Late follow-up of genital and ophthalmologic chronic graft-vs-host disease in females after allogeneic stem cell transplantation. [PDF]

Acta Obstet Gynecol Scand, 2022
Smith Knutsson E, Nicklasson M, Björk Y, Stenberg K, Sundfeldt K, Brune M.   +5 more
europepmc   +1 more source

Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease

, 1998
Eileen Smith, Irena Sniecinski, Andrew Dagis, Pablo Parker, David S. Snyder, Anthony S. Stein, Auayporn Nademanee, Margaret O’Donnell, Arturo Molina, G. Schmidt, Daniel E. Stepan, Neena Kapoor, Joyce C. Niland, Stephen J. Forman   +13 more
openalex   +1 more source